Specifically, secreted forms of ULBP4 (generated via alternative splicing) have been reported to bind to NKG2D receptor, thus initiating its internalization for NK cell-acquired dysfunction and reduced NK cytotoxicity for tumor immune escape (58–60). Here, RAET1E is linked to neoplasm.